To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
Dr. S. Vincent Rajkumar reviews his article appearing in the January 2020 issue of Mayo Clinic Proceedings which exposes the causes of and challenges for fixing the high cost of insulin in the United States.
David Almasi - Vice President of the National Center for Public Policy Research - confronted Merck CEO Ken Frazier about the pharmaceutical giant's relationship with the controversial Institute for Clinical and Economic Review (ICER).
In the last 5 years, cancer mortality has dropped 1.5 % equaling a financial reduction of approximately $750 Billion.
Debunking the myths supporting the current high costs associated with cancer treatment in the US.